 Boston Trust Walden Corp lifted its position in shares of Anika Therapeutics Inc NASDAQ:ANIK by 48.4 in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 326,319 shares of the biotechnology companys stock after acquiring an additional 106,501 shares during the quarter. Boston Trust Walden Corps holdings in ... 